Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-02, with 32 holding rows worth $601,702,000.

Accession
0001140361-18-035017
Filed
2018-08-02
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 32 entries on the cover page, a total value of $601,702,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $601,702,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Abbott Laboratories002824100COM1,064,562$64,928,000thousands by filing date
Merck & Co.,Inc.58933Y105COM913,830$55,469,000thousands by filing date
BAXTER INTL INC071813109COM721,058$53,243,000thousands by filing date
Bristol-Myers Squibb Company110122108COM902,226$49,929,000thousands by filing date
Boston Scientific Corporation101137107COM1,461,300$47,785,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO171,825$29,004,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR800,588$28,109,000thousands by filing date
REVVITY INC714046109COM362,956$26,579,000thousands by filing date
BIO RAD LABS INC090572207CL A86,449$24,944,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW326,659$21,040,000thousands by filing date
Elevance Health, Inc.036752103COM87,910$20,925,000thousands by filing date
Gilead Sciences,Inc.375558103COM291,600$20,657,000thousands by filing date
NUVASIVE INC670704105COM375,807$19,587,000thousands by filing date
Eli Lilly and Company532457108COM181,641$15,499,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock199,440$14,541,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock303,240$12,636,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock98,633$10,992,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK862,602$10,351,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock28,500$9,832,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW51,654$9,273,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK423,850$8,104,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM173,892$7,907,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock200,800$7,584,000thousands by filing date
PATTERSON COS INC703395103COM312,232$7,078,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM126,263$6,165,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM68,015$5,228,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock32,500$3,201,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock90,503$3,038,000thousands by filing date
BLUEBIRD BIO INC09609G100COM17,000$2,668,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM31,600$2,615,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM146,000$2,073,000thousands by filing date
REGENXBIO INC75901B107COM10,000$718,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-18-035017this filing2018-08-02acceptance time not in the bulk data set